Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease.
暂无分享,去创建一个
Paul D Mitchell | Andrew M Atz | S. Colan | B. McCrindle | J. Newburger | L. Sleeper | W. Gersony | R. Sundel | P. Mitchell | Jennifer S. Li | A. Atz | L. Minich | V. Vetter | Brian W McCrindle | Jane W Newburger | L LuAnn Minich | Masato Takahashi | Jennifer S Li | Masato Takahashi | Lynn A Sleeper | Steven D Colan | Welton Gersony | Victoria L Vetter | Annette L Baker | Gloria L Klein | Robert P Sundel | A. Baker | G. Klein | P. Mitchell
[1] J. Newburger,et al. Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids. , 1996, The Journal of pediatrics.
[2] M. Saleem,et al. Treatment of severe complicated Kawasaki disease with oral prednisolone and aspirin. , 2000, The Journal of pediatrics.
[3] S. Shulman. Is there a role for corticosteroids in Kawasaki disease? , 2003, The Journal of pediatrics.
[4] Tomio Kobayashi,et al. A multicenter prospective randomized trial of corticosteroids in primary therapy for Kawasaki disease: clinical course and coronary artery outcome. , 2006, The Journal of pediatrics.
[5] J. Saul,et al. The Pediatric Heart Network: A Primer for the Conduct of Multicenter Studies in Children with Congenital and Acquired Heart Disease , 2006, Pediatric Cardiology.
[6] Tomio Kobayashi,et al. Prediction of Intravenous Immunoglobulin Unresponsiveness in Patients With Kawasaki Disease , 2006, Circulation.
[7] Walter R Wilson,et al. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association , 2004, Pediatrics.
[8] S. Koike,et al. Kawasaki disease: effect of treatment on coronary artery involvement. , 1979, Pediatrics.
[9] J. Ioannidis,et al. Issues in comparisons between meta-analyses and large trials. , 1998, JAMA.
[10] S. Shulman,et al. Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose. , 1997, The Journal of pediatrics.
[11] M. Ishii,et al. Re‐treatment for immune globulin‐resistant Kawasaki disease: A comparative study of additional immune globulin and steroid pulse therapy , 2001, Pediatrics international : official journal of the Japan Pediatric Society.
[12] P. Ridker,et al. Discordance between Meta-analyses and Large-Scale Randomized, Controlled Trials: Examples from the Management of Acute Myocardial Infarction , 1995, Annals of Internal Medicine.
[13] T. Kamiya,et al. A trial procedure to prevent aneurysm formation of the coronary arteries by steroid pulse therapy in Kawasaki disease. , 1982, Japanese circulation journal.
[14] T. Matsuishi,et al. Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease. , 2006, The Journal of pediatrics.
[15] Tomio Kobayashi,et al. Effect of corticosteroids in addition to intravenous gamma globulin therapy on serum cytokine levels in the acute phase of Kawasaki disease in children. , 2003, The Journal of pediatrics.
[16] M. Freed,et al. Guidelines for long-term management of patients with Kawasaki disease. Report from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. , 1994, Circulation.
[17] J. Newburger. Treatment of Kawasaki disease: corticosteroids revisited. , 1999, The Journal of pediatrics.
[18] S. Kusakawa. Long‐term Administrative Care of Kawasaki Disease , 1983 .
[19] K. Sone,et al. Corticosteroids in the treatment of the acute phase of Kawasaki disease. , 1999, The Journal of pediatrics.
[20] S. Kurotobi,et al. Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment , 2006, European Journal of Pediatrics.
[21] S. Aronoff,et al. Effect of Initial Corticosteroid Therapy on Coronary Artery Aneurysm Formation in Kawasaki Disease: A Meta-analysis of 862 Children , 2005, Pediatrics.
[22] Natsuko Suzuki,et al. Rupture of coronary aneurysm in Kawasaki disease , 1999, Pediatrics international : official journal of the Japan Pediatric Society.
[23] J. Newburger,et al. Corticosteroids in the initial treatment of Kawasaki disease: report of a randomized trial. , 2003, The Journal of pediatrics.
[24] D. Sherry,et al. Initial intravenous gammaglobulin treatment failure in Kawasaki disease. , 2000, Pediatrics.
[25] J. Morgan. HOSPITAL FOR SICK CHILDREN. , 1884 .
[26] J. Furui,et al. Risk factors associated with the need for additional intravenous gamma-globulin therapy for Kawasaki disease. , 2006, Acta paediatrica.
[27] K. Durongpisitkul,et al. The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment. , 1995, Pediatrics.
[28] S. Colan,et al. Coronary artery dimensions may be misclassified as normal in Kawasaki disease. , 1998, The Journal of pediatrics.